There were differing accounts of whether the overseer of the Mueller probe would resign or insist that President Donald Trump fire him.
Deputy Attorney General Rod Rosenstein, whose job is not confirmed as active or expired, will join President Donald Trump on Thursday according to White House press secretary Sarah Sanders on Monday.
Rosenstein may even learn his fate during a visit to the White House on Monday, but, with Trump in New York for a meeting of the United Nations General Assembly, any determination on his future was halted. Rosenstein was in attendance on a regular basis at the White House and was still deputy attorney general when he left at midday.
The deputy attorney general explained on Saturday — with White House Counsel Don McGahn — that either Rosenstein suggested resigning or McGahn said he should consider leaving, NBC News’ Pete Williams reported.
Rosenstein’s job status became a concern after information surfaced last week that he had said he was wearing a wire to record President Trump and that he possibily organized a push to eject the president through a process created in the 25th Amendment to the Constitution.
“At the request of Deputy Attorney General Rod Rosenstein, he and President Trump had an extended conversation to discuss the recent news stories,” Sanders said in a statement. “They will meet on Thursday when the president returns to Washington, D.C.”
Thursday is also a date that Supreme Court nominee Brett Kavanaugh and Christine Blasey Ford, who has accused him of sexually assaulting her when they were in high school, are set to testify in front of the Senate Judiciary Committee. All allegations have been denied by Kavanaugh.
Rosenstein’s leaving would create doubt around the future of special counsel Robert Mueller’s Russia probe. This includes whether Mueller’s pending report is effectively brought to Congress and made public. President Trump has lfrustrated with Rosenstein over that targeting process and the Justice Department’s inaction for investigating agency officials whom the president think worked together against him.
Jay Sekulow who is one of the President’s personal lawyers, said on his radio show Monday that Rosenstein’s removal would demand a revision of the special counsel’s probe.
“I think it’s really important that there be a step back taken here, and a review, and I think it’s a review that has to be thorough and complete, and a review that has to include an investigation of what has transpired,” Sekulow said, terming such a reassessment “a timeout on this inquiry.”
A new deputy attorney general should “look at all of these allegations that are both surrounding this inquiry, and that initiated this inquiry, including the Christopher Steele dossier, and the appointment of the special counsel, and how all that plays in,” he said.
But it was the discussion of a wire and the 25th Amendment, first reported by The New York Times, that formed the proximate cause for Trump to justify forcing Rosenstein out.
Rosenstein said Friday that there is “no basis” for finding the president unfit to serve and that he never pursued any effort to record Trump.
Two administration officials told reporters from NBC News Friday that Rosenstein had discussed a wire in jest, but those who have talked about the event with then-Acting FBI Director Andrew McCabe, who was in the meeting in question with Rosenstein, explain he recalls the deputy attorney general being affirmed about quietly recording discussions with the President.
“Certainly it’s being looked at in terms of what took place, if anything took place,” President Trump said. “I’ll make a determination sometime later but I don’t have the facts.”
“Congress must take immediate steps to uphold the Constitution and the rule of law — which protects all of us — by shielding the Mueller investigation against President Trump’s obstruction,” Rep. Val Demings, D-Fla., said in a statement released while Rosenstein’s job status was still up in the air.
McCabe, who was fired by Attorney General Jeff Sessions, made a similar appeal.
“There is nothing more important to the integrity of law enforcement and the rule of law than protecting the investigation of Special Counsel Mueller,” he said in a statement. “I sacrificed personally and professionally to help put the investigation on a proper course and subsequently made every effort to protect it. … If the rumors of Deputy AG’s Rosenstein’s departure are true, I am deeply concerned that it puts that investigation at risk.”
Biotech Stocks To Watch In June: Cara Therapeutics (CARA) & Intellia Therapeutics (NTLA)
Among biotech companies, the competition between Cara Therapeutics Inc (CARA) and Intellia Therapeutics Inc (NTLA) has been an intriguing one. The two companies had been on the same level as far as the market cap goes during most of the year so far.
But Cara has now pulled ahead by as much as $150 million following positive data from its lead product candidate. That being said, it is also important to keep in mind that if an investor is looking at a long term investment, then the disparity in market cap between the two companies is a minor. Here’s a look at the pros and cons of Cara and Intellia.
Cara Therapeutics (CARA)
Cara Therapeutics is currently on the rise. Its lead product candidate Korsuva injection delivered highly encouraging results in its Phase 3 trial. It’s now believed that it would not be long before Cara has its first product on the market.
It is meant for the treatment of moderate-to-severe chronic kidney disease-associated pruritus. According to reports, the results were great. Another late-stage test is going to be conducted soon. The results could be announced by the end of this year. If Korsuve is approved, then it will be marketed by Fresenius Medical Care and Vifor Pharma Group.
Cara has entered joint ventures with those companies to market the product in the United States, Japan, and South Korea. An oral version of Korsuva is also in the pipeline and could prove to be another important development.
Intellia Therapeutics (NTLA)
Intellia Therapeutics (INTA) is involved in creating CRISPR gene editing therapies. It is a segment that has a lot of promise in the future. Even though the company is some years away from having anything on the market, the promise of gene editing therapy is exciting. So much so that Intellia has already found partners in big-ticket firms like Regeneron and Novartis.
Intellia is expected to file for FDA approval for the clinical study into its lead product NLTA-2001 in 2020. It is meant for the treatment of transthyretin amyloidosis, an uncommon genetic disease. Studies into the products have proven to be promising so far. The company is also working on a product to treat myeloid leukemia.
Now when it comes to choosing between Cara and Intellia, experts believe that the former could a better company. It’s already on the verge of having an approved product on the market. Intellia, on the other hand, is likely to be some years away from winning approval.
4 Security Penny Stocks To Watch
As Threats Arise, Security Stocks Take Center Stage In 2019
With the Federal Reserve’s meeting coming, the general market is bracing for anything. Meanwhile, penny stocks are continuing to climb at absurd rates. Trading penny stocks as of late has brought many investors fruitful profits and they look to continue this trend. Here are some security penny stocks to watch for the remainder of June 2019:
Security Penny Stock #1
Liberty Defense Holdings (SCAN.V)
Market Cap: $46.404M
Liberty Defense Holdings Ltd. (SCAN.V) is a security company looking to take the industry into the next century. Liberty’s HEXWAVE product is a 3-dimensional scanning device that can detect weapons and threats of any kind. The product can do this both with speed and discretion ensuring privacy for citizens.
Liberty signed a Memorandum of Understanding with the soccer team FC Bayern München to beta test HEXWAVE in their arena. They join an ever-growing list of places that have signed MOU’s to beta test Liberty’s product. This MOU expands its ability to comply with and test the market requirements for their product internationally.
“The reception to our HEXWAVE product has been fantastic and we are excited about working alongside FC Bayern Munich, a team that is a household name in both Europe and North America, […] Our ability to deploy in both indoor and outdoor settings, with covert and overt applications, sets us apart and has also been driving increasing interest from the market.”Bill Riker, CEO of Liberty
Security Penny Stock #2
Magal Security Systems (MAGS)
Market Cap: $101.371M
Magal Security Systems Ltd. (MAGS) provides security solutions both online and physical. Some services provided include identifying potential security problems, integrating new systems, and custom designs for any type of security needs.
Recently, Magal received a $5.5 million contract for its advanced perimeter intrusion detection system. The system prevents people from illegally crossing border fences and walls.
Dror Sharon, CEO of Magal, stated, “Magal is a world leader in perimeter intrusion technologies. Our growing wins of orders such as this – providing sensors for active international borders, is due to the decades of experience that we have in providing systems that have more than proven themselves in-the-field.”
Security Penny Stock #3
Rekor Systems (REKR)
Market Cap: $27.502M
Rekor Systems Inc. (REKR) is a company that has developed surveillance technology to enhance public safety, banking, and traffic management. Primarily, the company takes their advanced software, which utilizes machine learning and upgrades IP cameras to the next level. This reduces the cost when collecting highway tolls and helps manage traffic congestion.
Throughout June, Rekor Systems has been gaining recognition and application across the US. On June 3rd Rekor obtained a contract to start deploying its Mobile LBR-2 vehicle recognition systems. After this deployment on the 3rd, the LPR-2 system North Carolina law enforcement placed an order. On June 12th, Colorado highway authorities chose Rekor’s cloud system called NUMERUS to read enhance their license plate reading.
Security Penny Stock #4
BIO-key International (BKYI)
Market Cap: $18.03M
BIO-key International Inc. (BKYI) is a security technologies company that is pushing past the limits of fingerprint scanning. BIO-key provides a plethora of finger scanning products that provide security for your computer, hard drive, and the government. They have a partnership with Microsoft to develop biometric sign-in for Windows 10.
The company recently announced that a foreign defense ministry ordered more BIO-key deployment for secure access to Microsoft applications.
“We were delighted that such a capable and prestigious technology team determined that BIO-key met their security and scalability requirements and have now made follow-on investments to grow their user base. Defense Ministries are constant targets of cyber-attacks, and we are glad to help them step up authentication to the highest assurance with NIST-verified accuracy and FIPS compliance.”Jim Sullivan, SVP of BIO
Stock Price Pre Market Update – June 19, 2019
Big Investments Are Signaling The Green Light For A ‘Hot Market’ With Cancer-Fighting Stocks
How Tech Is Making Life Easier?
Healthcare Penny Stocks To Watch
Is Palatin Technologies (PTN) A Penny Stock To Buy Or Sell?
Search Stock Price (StockPrice.com)
Sponsored Content4 days ago
Special Delivery! On-Demand Tech Companies Hit Billion-Dollar Valuations; Here’s How Investors Can Capitalize In The Market
Featured3 months ago
Multi-Trillion Dollar Industry Providing Massive Opportunity in 2019 & Beyond
Cannabis2 months ago
Two Massive Growth Industries, One Choice for Investors
Featured5 days ago
This New Technology Could Transform A Multi-Billion-Dollar Industry!
Biotechnology2 weeks ago
Big Investments Are Signaling The Green Light For A ‘Hot Market’ With Cancer-Fighting Stocks
Cannabis3 weeks ago
A New Cannabis Trend That The Market Should Take Immediate Notice Of Is Here!
Featured2 months ago
Opportunity Ahead for This Healthcare Stock
Stock Market Breaking News4 weeks ago
Liberty Defense (SCAN.V) Signs MOU with the Utah Attorney General for Testing of HEXWAVE